Note: Araceli Biosciences's revenues are gauged from an analysis of company filings.
Araceli Biosciences's Income Statement (based on Industry Averages)
Araceli Biosciences P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Araceli Biosciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 26, 2023
3
56%
$4 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Araceli Biosciences is developing and marketing.
Araceli Biosciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CLAIRVOYANCE Scientific laboratory research instruments for cell and tissue imaging in the field of automated microscopy; Microscopes, namely, automated microscopes for use in research and drug discovery; Microscopes, namely, fluorescence microscopes; Automated microscope hardware and recorded operating software sold as a unit for use in laboratory operations; Computer hardware, namely, imaging hardware for microscopy; Downloadable software for processing, displaying, analyzing, and managing digital images in the field of microscopy; Non-medical imaging apparatus
01/09/2024
ENDEAVOR Scientific laboratory research instruments for use in drug discovery, drug development and safety assessments; computer hardware, namely, computer hardware for automated microscopic multi-well plate scanning in the field of high content screening or analysis including robotic automation and control; non-medical imaging apparatus for use in high content analysis including robotic automation and control; computer hardware for operating high content screening systems including robotic automation and control; digital input and output scanners for use in high content analysis; computer hardware for high content screening, namely, hardware for use in high content screening including robotic automation and control; computer hardware for digital imaging, namely, hardware for cell imaging systems; automated microscope hardware for use in laboratory operations; computer hardware, namely, imaging hardware for microscopy; computer hardware, namely, hardware for quantitative image analysis in the field of high content screening and phenotypic profiling; microscopes, namely, automated microscopes for use in research and drug discovery including robotic automation and control; microscopes, namely, fluorescence microscopes including robotic automation and control; microscopes, namely, automated microscopes for use in drug screening and development applications including robotic automation and control
05/22/2023
ARACELI VAERION Scientific laboratory research instruments for cell and tissue imaging in the field of automated microscopy; Microscopes, namely, automated microscopes for use in research and drug discovery; Microscopes, namely, fluorescence microscopes; Automated microscope hardware and recorded operating software sold as a unit for use in laboratory operations; Computer hardware, namely, imaging hardware for microscopy; Downloadable software for processing, displaying, analyzing, and managing digital images in the field of microscopy; Non-medical imaging apparatus
04/19/2023
See all trademarks and details in the Full Report.
Market Share of Araceli Biosciences's Largest Competitors
A competitive analysis shows these companies are in the same general field as Araceli Biosciences, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Araceli Biosciences.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Araceli Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.